ArticleScientific reports2025
Triglyceride-glucose index as a potential biomarker for predicting retinal vein occlusion.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Lipid Variability Predicts Long-Term Major Adverse Cardiovascular Events in MINOCA: A Retrospective Cohort Study.International journal of general medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The relationship between the triglyceride-glucose (TyG) index calculated using fasting blood glucose and triglyceride values was evaluated among 62 patients diagnosed with retinal vein occlusion (RVO) and 57 healthy volunteers. Patients were classified as having branch (BRVO) or central (CRVO) retinal vein occlusion. The mean age was 64.6 ± 12.4 in the BRVO group of 35 patients, 65.2 ± 13.0 in the CRVO group of 27 patients, and 62.8 ± 12.5 in the control group (p = 0.7). The frequency of hypertension was significantly higher in both CRVO and BRVO groups (p = 0.002). Fasting blood glucose and triglyceride were significantly higher and HDL-C was significantly lower in BRVO and CRVO patients compared to the control group (p = 0.003, p < 0.001, p = 0.005). TyG index were found to be significantly higher in patients with BRVO and CRVO (9.0 ± 0.5) compared to the control group (8.4 ± 0.4) (p < 0.001). Multivariate logistic regression analysis revealed that TyG index independently predicted BRVO (odds ratio = 4.53; 95% confidence interval = 1.78-11.55; p = 0.002) and any RVO (odds ratio = 6.82; 95% confidence interval = 2.75-16.90; p < 0.001). In receiver operating characteristics analysis, TyG index had an area under the curve of 0.785, and a TyG index greater than 8.85 predicted any RVO with 65% sensitivity and 82% specificity (p < 0.001). There is a significant association between high levels of TyG index and, in particular, both BRVO and any RVO. The TyG index can be a valuable biomarker in identifying individuals at risk of RVO.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.